Condition: COPD · Sponsor: Istituti Clinici Scientifici Maugeri SpA
Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease with related exercise intolerance and marked disability due to symptoms such as dyspnea and fatigue. Effort intolerance and exercise-induced symptoms cause marked impairment in completing activities of daily living (ADL). Pulmonary rehabilitation (PR), which has exercise as a major component, is considered a key treatment in the management of COPD since PR is effective in improving exercise tolerance, exercise-induced dyspnea and fatigue, and health-related quality of life. Rehabilitation is also effective in improving the time required to perform ADLs, reducing symptoms and disability. Studies show that rehabilitation protocols with upper limb exercises added to lower limb training are able to give additional benefits in terms of effort tolerance (endurance time at the arm ergometer and oxygen consumption) and reduction of dyspnea at iso-load. The primary aim of this study is to evaluate whether the combined "arm and leg" training modality, compared to a gold standard protocol -involving only the lower limbs training- is more effective in improving ADL performance in terms of reduction of exercise time for a specific test (GLITTRE test).
This description comes directly from the study's public registry record.
Mara Paneroni, MSc, PT · 0039+030+8253 · mara.paneroni@icsmaugeri.it
Tiziana Bachetti, Pharm · +0039+0382+593 · tiziana.bachetti@icsmaugeri.it
Always discuss trial participation with your own doctor first.
| ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Lumezzane | Lumezzane, Brescia, Italy | Recruiting |
| ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Montescano | Montescano, Pavia, Italy | Not Yet Recruiting |
| ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Tradate | Tradate, Varese, Italy | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05708443